Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children.

Drain, Paul; Sulaiman, Raed; Hoppers, Melanie; Lindner, Nigel M; Lawson, Vicki; Ellis, Jayne E

Drain, Paul; Sulaiman, Raed; Hoppers, Melanie; Lindner, Nigel M; Lawson, Vicki; Ellis, Jayne E.

Affiliation

Drain P; Department of Global Health and the Department of Medicine, University of Washington, Seattle, WA, USA.
Sulaiman R; Avera Research Institute, Sioux Falls, SD, USA.
Hoppers M; Clinical Research Solutions, Jackson, TN, USA.
Lindner NM; LumiraDx UK, London, UK.
Lawson V; LumiraDx UK, London, UK.
Ellis JE; LumiraDx UK, London, UK.

Am J Clin Pathol ; 157(4): 602-607, 2022 04 01.

Article in En | MEDLINE | ID: mdl-34668536

Subject(s)

COVID-19; SARS-CoV-2; Adult; Antigens, Viral/analysis; COVID-19/diagnosis; Child; Fluorescent Antibody Technique; Humans; Microfluidics; Point-of-Care Systems; Sensitivity and Specificity

Key words

Asymptomatic; COVID-19; LumiraDx antigen test; RT-PCR; SARS-CoV-2; Sensitivity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Child / Humans Language: En Journal: Am J Clin Pathol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google